Global Health

More from the Series

REPORTS
Understanding the Opportunity Cost, Seizing the Opportunity: Report of the Working Group on Incorporating Economics and Modelling in Global Health Goals and Guidelines
May 23, 2019
Internationally set goals and guidelines directly influ­ence the setting of health care priorities at the national level, affecting how limited resources are generated and allocated across health care needs. The Working Group on Incorporating Economics and Modelling in Global Health Goals and Gu...
Blog Post
Three Big Lessons for The Next Pandemic Response
May 16, 2019
The next pandemic is coming. We don’t know when it will hit or what it will be, but we do know that risk factors for the spread of infectious disease are worsening. The 2014–15 Ebola outbreak in West Africa provides a useful microcosm of the challenges a pandemic would pose. My new ...
Blog Post
We Asked, You Answered: Reflections on the First Round of MVAC Feedback
May 15, 2019
In March, our team at the Center for Global Development and Office of Health Economics posted a consultation draft of a policy proposal for a Market-Driven, Value-Based Advanced Commitment (MVAC). The MVAC is a new mechanism that puts middle-income country governments in the driver’s...
Blog Post
There is No Such Thing as Universal Health Coverage without…
May 02, 2019
On Monday, 600 delegates from development partners, NGOs, think tanks, and civil society organizations gathered at the United Nations in New York for an interactive multi-stakeholder hearing on Universal Health Coverage (UHC). Stakeholders discussed pertinent issues and inputs needed for a...
CGD NOTES
Aggregating Demand for Pharmaceuticals is Appealing, but Pooling Is Not a Panacea
May 01, 2019
As low- and middle-income countries shift away from donor support, their challenge will be finding a way to aggregate demand in order to achieve the benefits that the pooled purchasing arrangements of vertical health programs now provide. As a first step in tackling this challenge, much can be learn...
WORKING PAPERS
Who Benefits from Pharmaceutical Price Controls? Evidence from India - Working Paper 509
April 23, 2019
With the goal of driving down drug costs, governments across the globe have instituted various forms of pharmaceutical price control policies. In this paper, we examine the theoretical and empirical effects of one implementation of pharmaceutical price controls, in which the Indian government placed...
Blog Post
New High-Level Report Calls for Higher Taxes on Tobacco, Alcohol, and Sugary Beverages to Prevent Millions of Deaths
April 10, 2019
The Task Force on Fiscal Policy for Health, co-chaired by Michael Bloomberg and Lawrence Summers just launched a report calling on governments to substantially raise taxes on tobacco, alcohol, and sugary beverages. Such policies could avert an estimated 50 million premature deaths while raising...